Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Biometrical Journal. Biometrische Zeitschrift
|
October 27, 2010
Estimation of the diagnostic threshold accounting for decision costs and sampling uncertainty
Konstantina Skaltsa, Lluís Jover, Josep Lluís Carrasco
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
January 31, 2022
Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
Andrew Walding, Konstantina Skaltsa, Montserrat Casamayor, et al.
Journal of Biopharmaceutical Statistics
|
November 19, 2023
Reflections on estimands for patient-reported outcomes in cancer clinical trials
Rachael Lawrance, Konstantina Skaltsa, Antoine Regnault, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 24, 2022
Correction to: Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
Andrew Walding, Konstantina Skaltsa, Montserrat Casamayor, et al.
Statistics in Medicine
|
September 28, 2011
Optimum threshold estimation based on cost function in a multistate diagnostic setting
Konstantina Skaltsa, Lluís Jover, David Fuster, et al.
Dermatology and Therapy
|
July 30, 2024
Psychometric Evaluation of the Facial and Total Vitiligo Area Scoring Index Instruments in the TRuE-V Phase 3 Studies
Kristen Bibeau, Kathleen Butler, Mingyue Wang, et al.
Targeted Oncology
|
December 17, 2016
Adjusting Overall Survival Estimates after Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate Cancer
Konstantina Skaltsa, Cristina Ivanescu, Shevani Naidoo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2017
The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies
Tomasz M Beer, Kurt Miller, Bertrand Tombal, et al.
Clinical Lung Cancer
|
April 25, 2021
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies
Jared Weiss, Jerome Goldschmidt, Zoran Andric, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
September 1, 2015
Evaluation of Serial Arterial Lactate Levels as a Predictor of Hospital and Long-Term Mortality in Patients After Cardiac Surgery
Juan C Lopez-Delgado, Francisco Esteve, Casimiro Javierre, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Biometrical Journal. Biometrische Zeitschrift
|
October 27, 2010
Estimation of the diagnostic threshold accounting for decision costs and sampling uncertainty
Konstantina Skaltsa, Lluís Jover, Josep Lluís Carrasco
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
January 31, 2022
Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
Andrew Walding, Konstantina Skaltsa, Montserrat Casamayor, et al.
Journal of Biopharmaceutical Statistics
|
November 19, 2023
Reflections on estimands for patient-reported outcomes in cancer clinical trials
Rachael Lawrance, Konstantina Skaltsa, Antoine Regnault, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 24, 2022
Correction to: Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
Andrew Walding, Konstantina Skaltsa, Montserrat Casamayor, et al.
Statistics in Medicine
|
September 28, 2011
Optimum threshold estimation based on cost function in a multistate diagnostic setting
Konstantina Skaltsa, Lluís Jover, David Fuster, et al.
Dermatology and Therapy
|
July 30, 2024
Psychometric Evaluation of the Facial and Total Vitiligo Area Scoring Index Instruments in the TRuE-V Phase 3 Studies
Kristen Bibeau, Kathleen Butler, Mingyue Wang, et al.
Targeted Oncology
|
December 17, 2016
Adjusting Overall Survival Estimates after Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate Cancer
Konstantina Skaltsa, Cristina Ivanescu, Shevani Naidoo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 3, 2017
The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies
Tomasz M Beer, Kurt Miller, Bertrand Tombal, et al.
Clinical Lung Cancer
|
April 25, 2021
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies
Jared Weiss, Jerome Goldschmidt, Zoran Andric, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
September 1, 2015
Evaluation of Serial Arterial Lactate Levels as a Predictor of Hospital and Long-Term Mortality in Patients After Cardiac Surgery
Juan C Lopez-Delgado, Francisco Esteve, Casimiro Javierre, et al.
Page
of 2